Sonexa Therapeutics
Latest round
- Series A
Last raised
- Jan 2008
Total raised
- $30M
Investors
- 5
About Sonexa Therapeutics
Founded in 2007 and California, US, Sonexa Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops drug treatments and therapeutics for Alzheimer's disease and related disorders. The company's product ST101, an active molecule compound which is small and orally taken, penetrates through the blood-brain-barrier and restores learning and memory capability throughout animal models of cognitive impairment relevant to Alzheimer's.
Who invested in Sonexa Therapeutics
5 investors across 1 round
See all investors in Sonexa Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 31, 2008
Amount
$30M
Investors
Questions about Sonexa Therapeutics
Who invested in Sonexa Therapeutics?
Sonexa Therapeutics has 5 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Sonexa Therapeutics raised?
Sonexa Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Sonexa Therapeutics last raise money?
Sonexa Therapeutics's most recent round on record is a Series A, in Jan 2008.
What does Sonexa Therapeutics do?
Founded in 2007 and California, US, Sonexa Therapeutics, Inc.
Where is Sonexa Therapeutics headquartered?
Sonexa Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Sonexa Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Sonexa Therapeutics's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like Sonexa Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.